Harbin Pharmaceutical Group Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Harbin Pharmaceutical Group

Harbin Pharmaceutical Group

Harbin Pharmaceutical Group Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Harbin Pharmaceutical Group Co., Ltd. ( hereinafter referred to as "Habin Pharmaceutical Co., Ltd." ) is a large enterprise group integrating pharmaceutical manufacturing, trade and scientific research. In June 1993, the company was listed on the Shanghai Stock Exchange (stock code "600664").

The company covers three core business segments of industrial manufacturing, commerce and GNC. It has 10 industrial enterprises including Harbin Pharmaceutical Sanjing, Harbin Pharmaceutical General Factory, Harbin Pharmaceutical Six Factory, and Harbin Pharmaceutical Shiyitang. Harbin Pharmaceutical Renmin Tongtai (listed company ) and Harbin Pharmaceutical Marketing two commercial distribution companies, and also has a pharmaceutical research institute with strong scientific research capabilities, focusing on innovative research and development in high-tech fields such as central nervous system, anti-tumor, cardiovascular and cerebrovascular drugs.

Hayao Co., Ltd. has 1,816 drug approvals and 74 health food approvals. The leading products include calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, prostadil injection, and pediatric aminophen yellow. Namin granules, Rasidipin tablets, ceftiam hydrochloride for injection, ibuprofen granules, Xingai Zhonggai brand high calcium tablets, etc. The company owns five trademarks: "Haya Medicine", "Three Essences", "Guizhong Gai", "Hutong" and "Shiyitang", with a brand value of more than 20 billion yuan.

Integrity, professionalism, openness and inclusiveness, collaboration and responsibility, innovation and efficiency are the core values ​​of corporate development. Harbin Pharmaceutical Co., Ltd. is an enterprise with relatively innovative capabilities and pioneering spirit. In the future, the company will coordinate the talent chain, industrial chain and capital chain, comprehensively build an open innovation ecosystem, constantly explore high-quality development paths, and continue to make efforts in many fields such as products, technology, R&D, intelligent manufacturing, business models, and management mechanisms. Breakthrough and transformation make Harbin Pharmaceutical a benchmark for Chinese national pharmaceutical companies that consumers, customers, employees and society are proud of.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号